Vireo Growth Acquires Key NY Cannabis Facility for $88.5M, Secures $90M in Debt
Summary
Vireo Growth Inc. has acquired its 389,000 square foot cannabis cultivation and production facility in Perth, New York, for $88.5 million, funding the purchase with $90 million in new debt.
Key Events
-
Acquisition of Key Facility
Vireo's subsidiary acquired a 389,000 sq ft cannabis cultivation and production facility in Perth, NY, for $88.5 million by exercising a purchase option. This facility was previously leased by the company.
-
Significant Debt Incurred
The acquisition was financed through a $49 million seller-financed note at 15% interest (due May 2027, extendable) and a $41 million loan from Chicago Atlantic at prime plus 5.75% (due May 2028), totaling $90 million in new debt.
-
Strategic Asset Ownership
The company now owns a critical operational asset previously leased, enhancing control over its cannabis cultivation and production capabilities.
-
Continued Growth Strategy
This acquisition is consistent with Vireo's recent pattern of strategic expansions and strong financial performance, as highlighted in recent earnings reports and prior acquisition announcements.
Analysis
This acquisition of a previously leased, critical operational asset solidifies Vireo Growth's control over its supply chain and aligns with its aggressive growth strategy through strategic acquisitions. While the $88.5 million purchase price and the associated $90 million in new debt, including a $49 million note at a high 15% interest rate, introduce significant financial obligations, the move converts a lease expense into an owned asset. This follows a series of major acquisitions and strong financial results, indicating a continued expansion strategy.
At the time of this filing, VREOF was trading at $0.43 on OTC in the Life Sciences sector, with a market capitalization of approximately $503.5M. The 52-week trading range was $0.32 to $0.80. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.